SARS-CoV-2 mutations: The catalyst for a Covid-19 endemic?
Until more data for other vaccines become available, the AstraZeneca / Oxford vaccine is likely...
On 1 February, Concert Pharmaceuticals announced it was stopping development of its adjunctive treatment for...